Key Takeaway: Dr. Brenda Cooperstone has been a board member since 2019 and has a strong background in rare disease development at Pfizer. She previously worked at Wyeth Pharmaceuticals and has held various leadership roles, including Senior Vice President. Dr. Cooperstone's educational credentials include an M.D. from McGill University and specialized training in pediatrics and nephrology.
Price reaction · baseline $4.1 (2023-12-05T19:36:00.000Z) · hit during market hours · 4 other SNTI headline(s) in the window, move may be shared
day 0 close · peak
+2%
Market Sentiment Analysis
POSITIVE FACTORS
Dr. Cooperstone has extensive experience in the pharmaceutical industry.
She has held significant leadership roles at Pfizer.
Her educational background includes prestigious institutions.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+84%
120-day peak, hindsight
Typical move
76.7%
average across 4 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
SENTI-202
Phase 1 · AML/MDS
Full Press Release Details
Dr. Cooperstone has served as a member of our board of directors since 2019. Dr. Cooperstone has held various leadership positions at Pfizer including as Senior Vice President since 2017, Chief Development Officer for Rare Disease in Global Product Development since 2016 and Head of Development for Rare Disease in Global Product Development from 2015 to 2016. Dr. Cooperstone started her career in the pharmaceutical industry at Wyeth Pharmaceuticals in 1999 and joined Pfizer in 2009.
Dr. Cooperstone earned her M.D. from McGill University, and completed her residency in pediatrics at the Montreal Children’s Hospital, her clinical fellowship in pediatric nephrology at Children’s Hospital of Philadelphia and a research fellowship at the University of Pennsylvania’s Renal Electrolyte division.
Frequently Asked Questions
What positions has Dr. Cooperstone held at Pfizer?
Dr. Cooperstone has served as Senior Vice President and Chief Development Officer for Rare Disease.
Where did Dr. Cooperstone earn her medical degree?
She earned her M.D. from McGill University.
What is Dr. Cooperstone's experience in pediatrics?
She completed her residency in pediatrics at the Montreal Children’s Hospital.
When did Dr. Cooperstone join the board of directors?